Trial intelligence / Profile preview

Docetaxel and S-1 vs S-1 in Advanced Gastric Cancer

NCT00287768Phase 3Completed

Sponsor
Japan Clinical Cancer Research Organization
Start
Mar 2006
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel in gastric cancer (GC), sponsored by Japan Clinical Cancer Research Organization. Started Mar 2006; status: completed.

02

Drugs

docetaxel
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00287768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00287768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call